Loading
IF
INVO Fertility, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Goren Andrea, was filed 03 Jun 2022.
INVO Fertility, Inc.: what insiders have been doing
INVO Fertility, Inc. is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). From 23 October 2025 to 23 October 2026, the disclosure feed for INVO Fertility, Inc. logged 2 filings by 1 insider.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €5. Biggest ticket of the year: €5, sold by Szot Matthew K and made public on 5 December 2025.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Compared with its exchange (3,167 companies, median 24 filings), a count of 2 filings is below the norm. Over the whole record (from 2017), the tally stands at 25 purchases and 53 sales. The 10-K for the year ended 31 December 2025 shows 6.8 m USD of revenue and -23.3 m USD of net income.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
110
Thresholds
n/a
Buy Volume
€843,530
25 ops. · all time
Sell Volume
€199,629
53 ops. · all time
Who traded when
BuySaleMatthew K. Szot1 sale
Since the insiders bought
- -78.9%Entry US$27,244.80 · Close at T+365 US$5,760.00
- -78.9%Entry US$27,244.80 · Close at T+365 US$5,760.00
- -78.9%Entry US$27,244.80 · Close at T+365 US$5,760.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.60
Analyst consensus
1 analystsUS$20.00Target US$20.00(+3228%)US$20.00
Income statement
RevenueUS$6.8M
Gross profitUS$2.5M37% margin
EBITDA-US$3.5M-51% margin
Net income-US$23.3M-92.3% margin
Valuation
PER (trailing)0.0x
PER (forward)-0.1x
P/Book0.1x
Balance sheet & cash
Market capUS$2.8M
Total debtUS$3.4M
Free Cash Flow-US$7.1M
Debt / Equity24%
Profitability & ownership
ROE-72.7%
ROA-16.4%
% insiders0.9%
% institutions14.7%
Last declaration on 5 December 2025
Declarations110 total
3 shares0Common stockSEC:0001493152-25-026483:1
4 shares@ US$1.52100.0% of flowCommon stockSEC:0001493152-25-026483:0
58,885 shares@ US$0.9537.8% of flowCommon StockSEC:0001493152-22-015912:0
Canonical exit: 30 Aug 2022 (T+90)
14,474 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015909:0
Canonical exit: 30 Aug 2022 (T+90)
10,526 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015907:0
Canonical exit: 30 Aug 2022 (T+90)
52,632 shares@ US$0.9535.2% of flowCommon StockSEC:0001493152-22-015906:0
Canonical exit: 30 Aug 2022 (T+90)
11,184 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015910:0
Canonical exit: 30 Aug 2022 (T+90)
9,211 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015908:0
Canonical exit: 30 Aug 2022 (T+90)
10,526 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015911:0
Canonical exit: 30 Aug 2022 (T+90)
9,868 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015905:0
Canonical exit: 30 Aug 2022 (T+90)
177,306 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015904:0
Canonical exit: 30 Aug 2022 (T+90)
10,250 shares0Common StockSEC:0001493152-22-001531:0
15,236 shares0Common StockSEC:0001493152-22-001533:0
8,865 shares0Common StockSEC:0001493152-22-001536:0
8,588 shares0Common StockSEC:0001493152-22-001529:0
7,480 shares0Common StockSEC:0001493152-22-001535:0
8,311 shares0Common StockSEC:0001493152-22-001530:0
20,111 shares0Common StockSEC:0001493152-22-001532:0
5,361 shares0Common StockSEC:0001493152-22-001528:0
8,034 shares0Common StockSEC:0001493152-22-001534:0
30,674 shares@ US$3.2662.2% of flowCommon StockSEC:0001493152-21-024950:0
Canonical exit: 3 Jan 2022 (T+90)
30,674 shares@ US$3.2664.8% of flowCommon StockSEC:0001493152-21-024951:0
Canonical exit: 3 Jan 2022 (T+90)
4,806 shares0Common StockSEC:0001493152-21-011367:0
1,000 shares@ US$3.765.7% of flowCommon StockSEC:0001535264-21-000033:0
Canonical exit: 8 Aug 2021 (T+90)
27,811 shares@ US$4.0826.8% of flowCommon StockSEC:0001535264-21-000032:1
Canonical exit: 8 Jul 2021 (T+90)
25 of 110 declarations
About INVO Fertility, Inc.
INVO Fertility, Inc. is a company specializing in fertility technologies, providing innovative solutions for couples seeking to conceive. It is listed on NASDAQ under the ticker INVO.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
